Lifecore Biomedical Inc (NAS:LFCR)
$ 7.41 -0.085 (-1.13%) Market Cap: 272.89 Mil Enterprise Value: 404.23 Mil PE Ratio: 148.20 PB Ratio: 0 GF Score: 65/100

Q1 2021 Landec Corp Earnings Call Transcript

Oct 06, 2020 / 09:00PM GMT
Release Date Price: $10.52 (+5.41%)
Operator

Good afternoon, and thank you for joining Landec's Fiscal 2021 First Quarter Earnings Call. With me on the call today is Dr. Albert Bolles, Landec's Chief Executive Officer; Brian McLaughlin, Landec's Chief Financial Officer; and Jim Hall, President of Lifecore.

During today's call, we may make forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially. These risks are outlined in our filings with the Securities and Exchange Commission, including the company's Form 10-K for fiscal year 2020.

Let me turn the conference over to Al Bolles.

Albert D. Bolles
Landec Corporation - CEO, President & Director

Thank you, and good afternoon, everyone. As a leading innovator in diversified health and wellness solutions, Landec is comprised of 2 operating businesses: Lifecore Biomedical and Curation Foods. Landec designs, develops, manufactures and sells products for the food and pharmaceutical industry. Lifecore Biomedical is a fully integrated contract development and manufacturing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot